2m 2m 2m 2m 2m 2m 2m
Harrow (HROW)
NASDAQ
$33.23+$0.37 (+1.11%)
Price as of Jun 03, 2026 6:09 PM EDT- $1.3BMarket Cap
- 12.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Harrow (HROW)
$33.23+$0.37 (+1.11%)
HROW | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $32.86 | ||
Change | -$1.25 (-3.66%) | ||
Open | $33.96 | ||
High | $34.65 | ||
Low | $32.73 | ||
Previous Close | $34.11 | ||
Volume | 587,921 | ||
30-Day Average Volume | 1,048,963 | ||
1-Week Change | -3.83% | ||
1-Month Change | -19.66% | ||
1-Year Change | 12.00% | ||
3-Year Change | 68.00% | ||
5-Year Change | 254.48% | ||
Fundamentals | |||
Shares Outstanding | 37.3M | ||
Total Assets | $419.5M | ||
Market Cap | $1.3B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$9.2M | ||
EBIT | $25,000.00 | ||
EBITDA | $480,000.00 | ||
Net Working Capital | $134.9M | ||
EPS | -$0.74 | ||
Enterprise Value/EBITDA | 3,146 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 46 | ||
P/E | -48 | ||
PEG | N/A | ||
Price/Free Cash Flow | -143 | ||
Price/Operating Cash Flow | -146 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 02/08/2013 | ||
Earnings & Revenue